GlassScriptPhysician profile
Firas Rafati
NPI 1942655949
$1,719.34
in general payments reported to CMS, 2019-2025
17 companies · $71.92 in 2025
The $71.92 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $150 · 2021: $288 · 2022: $290 · 2023: $726 · 2024: $193 · 2025: $71.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $588.07 | 2021-2023 | Senza |
| Boston Scientific Corporation | $210.14 | 2020-2023 | |
| Abbott Laboratories | $188.07 | 2023-2025 | Proclaim |
| Medtronic, INC. | $153.35 | 2021-2023 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $135.23 | 2022-2025 | Belbuca, Xtampza |
| Stryker Corporation | $76.53 | 2024 | Everest Spinal System, Prolift, Cascadia Interbody System |
| Kowa Pharmaceuticals America, INC. | $73.44 | 2023 | Seglentis |
| Lilly USA, LLC | $43.74 | 2023 | Emgality, Reyvow |
| Abbvie INC. | $38.89 | 2023-2024 | |
| Stimwave Technologies Incorporated | $36.85 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $35.69 | 2023 | Iovera, Zilretta |
| Vertex Pharmaceuticals Incorporated | $28.82 | 2025 | |
| Merz Pharmaceuticals, LLC | $27.78 | 2024 | Xeomin |
| Pfizer INC. | $27.19 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $16.68 | 2021 | |
| Foundation Fusion Solutions, LLC | $13.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Firas Rafati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.